Spinocerebellar degenerations

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 113-140

  Perlman, Susan L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN;

ATAXIA; BOOK; CEREBELLUM; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SPINOCEREBELLAR DEGENERATION;

ATAXIA; CEREBELLUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE TISSUE PROTEINS; PHENOTYPE; SPINOCEREBELLAR DEGENERATIONS;

EID: 79954471815     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00006-9     Document Type: Book

References (173)

1. Abele M., Schols L., Schwartz S., et al. Prevalence of antigliadin antibodies in ataxia patients. Neurology 2003, 60:1674-1675.
2. Abe T., Abe K., Tsuda T., et al. Ophthalmological findings in patients with spinocerebellar ataxia type 1 are not correlated with neurological anticipation. Graefes Arch Clin Exp Ophthalmol 2001, 239:722-728.
3. Auburger G., Ratzlaff T., Lunkes A., et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2cm between D1S443 and D1S197. Genomics 1996, 31:90-94.
4. Baloh R.W., Jen J.C. Genetics of familial episodic vertigo and ataxia. Ann N Y Acad Sci 2002, 956:338-345.
5. Banfi S., Servadio A., Chung M.Y., et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 1994, 7:513-520.
6. Bang O.Y., Lee P.H., Kim S.Y., et al. Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. J Neurol Neurosurg Psychiatry 2004, 75:1452-1456.
7. Bauer P., Laccone F., Rolfs A., et al. Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet 2004, 41:230-232.
8. Berry-Kravis E., Abrams L., Coffey S.M., et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord 2007, 22:2018-2030. quiz 2140.
9. Bianca M., Bianca S., Vecchio I., et al. Gerstmann-Straussler-Scheinker disease with P102L-V129 mutation: a case with psychiatric manifestations at onset. Ann Genet 2003, 46:467-469.
10. Biton S., Barzilai A., Shiloh Y. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle. DNA Repair (Amst) 2008, 7:1028-1038.
11. Bratosiewicz-Wasik J., Wasik T.J., Liberski P.P. Molecular approaches to mechanisms of prion diseases. Folia Neuropathol 2004, 42:33-46.
12. Brkanac Z., Bylenok L., Fernandez M., et al. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol 2002, 59:1291-1295.
13. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
14. Bruni A.C., Takahashi-Fujigasaki J., Maltecca F., et al. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 2004, 61:1314-1320.
15. Burk K., Fetter M., Abele M., et al. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol 1999, 246:789-797.
16. Bushara K.O., Goebel S.U., Shill H., et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001, 49:540-543.
17. Buttner N., Geschwind D., Jen J.C., et al. Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol 1998, 55:1353-1357.
18. Cancel G., Durr A., Didierjean O., et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet 1997, 6:709-715.
19. Cancel G., Gourfinkel-An I., Stevanin G., et al. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease. Hum Mutat 1998, 11:23-27.
20. Cemal C.K., Carroll C.J., Lawrence L., et al. YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit. Hum Mol Genet 2002, 11:1075-1094.
21. Chen D.H., Brkanac Z., Verlinde C.L., et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 2003, 72:839-849.
22. Chen S., Peng G.H., Wang X., et al. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization. Hum Mol Genet 2004, 13:53-67.
23. Ciosk R., DePalma M., Priess J.R. ATX-2, the C. Elegans ortholog of ataxin 2, functions in translational regulation in the germline. Development 2004, 131:4831-4841.
24. Clark H.B., Orr H.T. Spinocerebellar ataxia type 1 - modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice. J Neuropathol Exp Neurol 2000, 59:265-270.
25. Clark H.B., Burright E.N., Yunis W.S., et al. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci 1997, 17:7385-7395.
26. Costanzi-Porrini S., Tessarolo D., Abbruzzese C., et al. An interrupted 34-CAG repeat SCA-2 allele in patients with sporadic spinocerebellar ataxia. Neurology 2000, 54:491-493.
27. Cummings C.J., Sun Y., Opal P., et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 2001, 10:1511-1518.
28. Damji K.F., Allingham R.R., Pollock S.C., et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol 1996, 53:338-344.
29. David G., Abbas N., Stevanin G., et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997, 17:65-70.
30. David G., Durr A., Stevanin G., et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet 1998, 7:165-170.
31. De Michele G., Maltecca F., Carella M., et al. Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci 2003, 24:166-167.
32. Devos D., Schraen-Maschke S., Vuillaume I., et al. Clinical features and genetic analysis of a new form of spinocerebellar ataxia. Neurology 2001, 56:234-238.
33. Dudding T.E., Friend K., Schofield P.W., et al. Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus. Neurology 2004, 63:2288-2292.
34. Erdmann V.A., Barciszewska M.Z., Szymanski M., et al. The non-coding rnas as riboregulators. Nucleic Acids Res 2001, 29:189-193.
35. Escayg A., Jones J.M., Kearney J.A., et al. Calcium channel beta 4 (CACNB4): human ortholog of the mouse epilepsy gene lethargic. Genomics 1998, 50:14-22.
36. Flechsig E., Hegyi I., Leimeroth R., et al. Expression of truncated prp targeted to Purkinje cells of prp knockout mice causes Purkinje cell death and ataxia. Embo J 2003, 22:3095-3101.
37. Frontali M. Spinocerebellar ataxia type 6: channelopathy or glutamine repeat disorder?. Brain Res Bull 2001, 56:227-231.
38. Furtado S., Payami H., Lockhart P.J., et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 2004, 19:622-629.
39. Gambetti P., Kong Q., Zou W., et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003, 66:213-239.
40. Ghetti B., Tagliavini F., Takao M., et al. Hereditary prion protein amyloidoses. Clin Lab Med 2003, 23:65-85. viii.
41. Gilman S., Wenning G.K., Low P.A., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
42. Goldfarb L.G., Vasconcelos O., Platonov F.A., et al. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol 1996, 39:500-506.
43. Gonzalez-Alegre P., Paulson H.L. Technology insight: therapeutic RNA interference - how far from the neurology clinic?. Nat Clin Pract Neurol 2007, 3:394-404.
44. Goto J., Watanabe M., Ichikawa Y., et al. Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci Res 1997, 28:373-377.
45. Grote S.K., La Spada A.R. Insights into the molecular basis of polyglutamine neurodegeneration from studies of a spinocerebellar ataxia type 7 mouse model. Cytogenet Genome Res 2003, 100:164-174.
46. Guerrini L., Lolli F., Ginestroni A., et al. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain 2004, 127:1785-1795.
47. Haan J., Kors E.E., van den Maagdenberg A.M., et al. Toward a molecular genetic classification of familial hemiplegic migraine. Curr Pain Headache Rep 2004, 8:238-243.
48. Hadjivassiliou M., Grunewald R., Sharrack B., et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 2003, 126:685-691.
49. Hanna M.G., Davis M.B., Sweeney M.G., et al. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Disord 1998, 13:339-340.
50. Hara K., Fukushima T., Suzuki T., et al. Japanese SCA families with an unusual phenotype linked to a locus overlapping with SCA15 locus. Neurology 2004, 62:648-651.
51. Hara K., Momose Y., Tokiguchi S., et al. Multiplex families with multiple system atrophy. Arch Neurol 2007, 64:545-551.
52. Harding A.E. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. Brain 1982, 105:1-28.
53. Helmlinger D., Hardy S., Sasorith S., et al. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. Hum Mol Genet 2004, 13:1257-1265.
54. Hockly E., Richon V.M., Woodman B., et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 2003, 100:2041-2046.
55. Holmes S.E., O'Hearn E.E., McInnis M.G., et al. Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat Genet 1999, 23:391-392.
56. Holmes S.E., Hearn E.O., Ross C.A., et al. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull 2001, 56:397-403.
57. Huynh D.P., Figueroa K., Hoang N., et al. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 2000, 26:44-50.
58. Huynh D.P., Yang H.T., Vakharia H., et al. Expansion of the polyq repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. Hum Mol Genet 2003, 12:1485-1496.
59. Ikeda Y., Dalton J.C., Moseley M.L., et al. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet 2004, 75:3-16.
60. Imbert G., Saudou F., Yvert G., et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996, 14:285-291.
61. Jen J.C. Hereditary episodic ataxias. Ann N Y Acad Sci 2008, 1142:250-253.
62. Jen J.C. Recent advances in the genetics of recurrent vertigo and vestibulopathy. Curr Opin Neurol 2008, 21:3-7.
63. Jen J.C., Baloh R.W. Genetics of episodic ataxia. Adv Neurol 2002, 89:459-461.
64. Jen J., Kim G.W., Baloh R.W. Clinical spectrum of episodic ataxia type 2. Neurology 2004, 62:17-22.
65. Kawaguchi Y., Okamoto T., Taniwaki M., et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994, 8:221-228.
66. Klein A., Boltshauser E., Jen J., et al. Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy. Neuropediatrics 2004, 35:147-149.
67. Klockgether T., Burk K., Wullner U., et al. Risk factors for idiopathic cerebellar ataxia of late onset. J Neurol Sci 1998, 160:171-174.
68. Klockgether T., Skalej M., Wedekind D., et al. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain 1998, 121:1687-1693.
69. Knight M.A., Kennerson M.L., Anney R.J., et al. Spinocerebellar ataxia type 15 (sca15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant. Neurobiol Dis 2003, 13:147-157.
70. Knight M.A., Gardner R.J., Bahlo M., et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain 2004, 127:1172-1181.
71. Knight R.S., Will R.G. Prion diseases. J Neurol Neurosurg Psychiatry 2004, 75:i36-i42.
72. Koeppen A.H., Michael S.C., Knutson M.D., et al. The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins. Acta Neuropathol 2007, 114:163-173.
73. Koide R., Kobayashi S., Shimohata T., et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?. Hum Mol Genet 1999, 8:2047-2053.
74. Kovacs G.G., Kalev O., Budka H. Contribution of neuropathology to the understanding of human prion disease. Folia Neuropathol 2004, 42:69-76.
75. Kovacs G.G., Voigtlander T., Gelpi E., et al. Rationale for diagnosing human prion disease. World J Biol Psychiatry 2004, 5:83-91.
76. Kullmann D.M., Hanna M.G. Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol 2002, 1:157-166.
77. La Spada A.R., Taylor J.P. Polyglutamines placed into context. Neuron 2003, 38:681-684.
78. La Spada A.R., Fu Y.H., Sopher B.L., et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 2001, 31:913-927.
79. Le Ber I., Camuzat A., Castelnovo G., et al. Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. Arch Neurol 2003, 60:1097-1099.
80. Lee E.S., Moon H.K., Park Y.H., et al. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene. J Neurol Sci 2004, 224:83-87.
81. Liberski P.P. Prion diseases: a riddle wrapped in a mystery inside an enigma. Folia Neuropathol 2008, 46:93-116.
82. Licht D.J., Lynch D.R. Juvenile dentatorubral-pallidoluysian atrophy: new clinical features. Pediatr Neurol 2002, 26:51-54.
83. Lin Y., Zheng J.Y., Jin Y.H., et al. Trinucleotide expansions in the SCA7 gene in a large family with spinocerebellar ataxia and craniocervical dystonia. Neurosci Lett 2008, 434:230-233.
84. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
85. Liu Y.F., Yang U.C. SCA db: Spinocerebellar ataxia candidate gene database. Bioinformatics 2004, 20:2656-2661.
86. Li Y., Yokota T., Matsumura R., et al. Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA. Ann Neurol 2004, 56:124-129.
87. Maciel P., Lopes-Cendes I., Kish S., et al. Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients. Am J Hum Genet 1997, 60:993-996.
88. Maciel P., Gaspar C., Guimaraes L., et al. Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract. Eur J Hum Genet 1999, 7:147-156.
89. Maltecca F., Filla A., Castaldo I., et al. Intergenerational instability and marked anticipation in SCA-17. Neurology 2003, 61:1441-1443.
90. Mantuano E., Veneziano L., Jodice C., et al. Spinocerebellar ataxia type 6 and episodic ataxia type 2: differences and similarities between two allelic disorders. Cytogenet Genome Res 2003, 100:147-153.
91. Mascalchi M., Tosetti M., Plasmati R., et al. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1. Ann Neurol 1998, 43:244-252.
92. Matilla A., Koshy B.T., Cummings C.J., et al. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 1997, 389:974-978.
93. Matsuura T., Sasaki H., Yabe I., et al. Mosaicism of unstable CAG repeats in the brain of spinocerebellar ataxia type 2. J Neurol 1999, 246:835-839.
94. Matsuyama Z., Yanagisawa N.K., Aoki Y., et al. Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of cav2.1 Ca2+ channel - loss-of-function cellular model of SCA6. Neurobiol Dis 2004, 17:198-204.
95. Mavrou A., Tsangaris G.T., Roma E., et al. The ATM gene and ataxia telangiectasia. Anticancer Res 2008, 28:401-405.
96. Michael S., Petrocine S.V., Qian J., et al. Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia. Cerebellum 2006, 5:257-267.
97. Michalik A., Van Broechkhoven C. Proteasome degrades soluble expanded polyglutamine completely and efficiently. Neurobiol Dis 2004, 16:202-211.
98. Michalik A., Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 2003, 12:R173-R186.
99. Moretti P., Blazo M., Garcia L., et al. Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy. Am J Med Genet A 2004, 124:392-396.
100. Moseley M.L., Benzow K.A., Schut L.J., et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998, 51:1666-1671.
101. Mosemiller A.K., Dalton J.C., Day J.W., et al. Molecular genetics of spinocerebellar ataxia type 8 (SCA8). Cytogenet Genome Res 2003, 100:175-183.
102. Murata Y., Kawakami H., Yamaguchi S., et al. Characteristic magnetic resonance imaging findings in spinocerebellar ataxia 6. Arch Neurol 1998, 55:1348-1352.
103. Mutsuddi M., Marshall C.M., Benzow K.A., et al. The spinocerebellar ataxia 8 noncoding RNA causes neurodegeneration and associates with staufen in Drosophila. Curr Biol 2004, 14:302-308.
104. Nagaoka U., Suzuki Y., Kawanami T., et al. Regional differences in genetic subgroup frequency in hereditary cerebellar ataxia, and a morphometrical study of brain MR images in SCA1, MJD and SCA6. J Neurol Sci 1999, 164:187-194.
105. Nakamura K., Jeong S.Y., Uchihara T., et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001, 10:1441-1448.
106. Nechiporuk A., Lopes-Cendes I., Nechiporuk T., et al. Genetic mapping of the spinocerebellar ataxia type 2 gene on human chromosome 12. Neurology 1996, 46:1731-1735.
107. Nikali K., Suomalainen A., Terwilliger J., et al. Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus. Am J Hum Genet 1995, 56:1088-1095.
108. Opal P., Garcia J.J., Propst F., et al. Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis. J Biol Chem 2003, 278:34691-34699.
109. Ozawa T. Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum. Acta Neuropathol 2006, 112:531-538.
110. Pandolfo M. Friedreich ataxia. Arch Neurol 2008, 65:1296-1303.
111. Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol 2009, 256:3-8.
112. Pandolfo M., Pastore A. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J Neurol 2009, 256:9-17.
113. Perlman S. Diagnostic evaluation of ataxic patients. Genetics of Movement Disorders 2003, Academic Press, San Diego. S.M. Pulst (Ed.).
114. Perlman S.L. Symptomatic and disease-modifying therapy for the progressive ataxias. Neurologist 2004, 10:275-289.
115. Povey S., Lovering R., Bruford E., et al. The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 2001, 109:678-680.
116. Pujana M.A., Volpini V., Gratacos M., et al. Uncloned expanded CAG/CTG repeat sequences in autosomal dominant cerebellar ataxia (ADCA) detected by the repeat expansion detection (RED) method. J Med Genet 1998, 35:99-102.
117. Pulst S.M. Introduction to medical genetics and methods of DNA testing. Genetics of Movement Disorders 2003, Academic Press, San Diego. S.M. Pulst (Ed.).
118. Rolfs A., Koeppen A.H., Bauer I., et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 2003, 54:367-375.
119. Rubinsztein D.C., Leggo J. Non-Mendelian transmission at the Machado-Joseph disease locus in normal females: preferential transmission of alleles with smaller CAG repeats. J Med Genet 1997, 34:234-236.
120. Sanjo N. Acquired Creutzfeldt-Jakob disease (CJD)-Kuru, iatrogenic CJD, variant CJD. Nippon Rinsho 2007, 65:1438-1445.
121. Sanpei K., Takano H., Igarashi S., et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 1996, 14:277-284.
122. Sasaki H. Unstable expansion of CAG repeat and molecular mechanism of neurodegeneration in SCA1. Nippon Rinsho 1999, 57:801-804.
123. Sato T., Oyake M., Nakamura K., et al. Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Hum Mol Genet 1999, 8:99-106.
124. Schelhaas H.J., Ippel P.F., Hageman G., et al. Clinical and genetic analysis of a four-generation family with a distinct autosomal dominant cerebellar ataxia. J Neurol 2001, 248:113-120.
125. Schilling G., Wood J.D., Duan K., et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 1999, 24:275-286.
126. Schmitz-Hubsch T., Coudert M., Bauer P., et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology 2008, 71:982-989.
127. Schols L., Amoiridis G., Langkafel M., et al. Motor evoked potentials in the spinocerebellar ataxias type 1 and type 3. Muscle Nerve 1997, 20:226-228.
128. Schols L., Bauer P., Schmidt T., et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
129. Scholz S.W., Houlden H., Schulte C., et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009, 65:610-614.
130. Shakkottai V.G., Chou C.H., Oddo S., et al. Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. J Clin Invest 2004, 113:582-590.
131. Skinner P.J., Vierra-Green C.A., Clark H.B., et al. Altered trafficking of membrane proteins in purkinje cells of SCA1 transgenic mice. Am J Pathol 2001, 159:905-913.
132. Smallwood P.M., Munoz-Sanjuan I., Tong P., et al. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci U S A 1996, 93:9850-9857.
133. Smith C.O., Lipe H.P., Bird T.D. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol 2004, 61:875-880.
134. Soong B.W., Paulson H.L. Spinocerebellar ataxias: an update. Curr Opin Neurol 2007, 20:438-446.
135. Spacey S.D., Szczygielski B.I., Young S.P., et al. Malaysian siblings with Friedreich ataxia and chorea: a novel deletion in the frataxin gene. Can J Neurol Sci 2004, 31:383-386.
136. Spadaro M., Ursu S., Lehmann-Horn F., et al. A G301R Na+/K+-atpase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 2004, 5:177-185.
137. Srivastava A.K., Choudhry S., Gopinath M.S., et al. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neurol 2001, 50:796-800.
138. Steckley J.L., Ebers G.C., Cader M.Z., et al. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology 2001, 57:1499-1502.
139. Stevanin G., Fujigasaki H., Lebre A.S., et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 2003, 126:1599-1603.
140. Stevanin G., Hahn V., Lohmann E., et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol 2004, 61:1242-1248.
141. Takano H., Cancel G., Ikeuchi T., et al. Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am J Hum Genet 1998, 63:1060-1066.
142. Takao M., Kadowaki T., Tomita Y., et al. 'Hot-cross bun sign' of multiple system atrophy. Intern Med 2007, 46:1883.
143. Takiyama Y., Sakoe K., Soutome M., et al. Single sperm analysis of the CAG repeats in the gene for Machado-Joseph disease (MJD1): evidence for non-Mendelian transmission of the MJD1 gene and for the effect of the intragenic CGG/GGG polymorphism on the intergenerational instability. Hum Mol Genet 1997, 6:1063-1068.
144. Tarlac V., Storey E. Role of proteolysis in polyglutamine disorders. J Neurosci Res 2003, 74:406-416.
145. Taroni F., DiDonato S. Pathways to motor incoordination: the inherited ataxias. Nat Rev Neurosci 2004, 5:641-655.
146. Toyoshima Y., Yamada M., Onodera O., et al. SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol 2004, 55:281-286.
147. Tsuji S. [Dentatorubral-pallidoluysian atrophy (DRPLA) - discovery of the disease, DRPLA gene and the pathophysiology]. Rinsho Shinkeigaku 2000, 40:1287-1289.
148. van de Warrenburg B.P., Verbeek D.S., Piersma S.J., et al. Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology 2003, 61:1760-1765.
149. van Swieten J.C., Brusse E., de Graaf B.M., et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet 2003, 72:191-199.
150. Velazquez-Perez L., Seifried C., Santos-Falcon N., et al. Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2. Ann Neurol 2004, 56:444-447.
151. Verbeek D.S., Schelhaas J.H., Ippel E.F., et al. Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21. Hum Genet 2002, 111:388-393.
152. Verbeek D.S., Knight M.A., Harmison G.G., et al. Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. Brain 2004, 128:436-442.
153. Vuillaume I., Devos D., Schraen-Maschke S., et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol 2002, 52:666-670.
154. Wain H.M., Bruford E.A., Lovering R.C., et al. Guidelines for human gene nomenclature. Genomics 2002, 79:464-470.
155. Wain H.M., Lush M., Ducluzeau F., et al. Genew: the human gene nomenclature database. Nucleic Acids Res 2002, 30:169-171.
156. Wang Q., Bardgett M.E., Wong M., et al. Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron 2002, 35:25-38.
157. Watase K., Zoghbi H.Y. Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet 2003, 4:296-307.
158. Watase K., Venken K.J., Sun Y., et al. Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1. Hum Mol Genet 2003, 12:2789-2795.
159. Wenning G.K., Stefanova N., Jellinger K.A., et al. Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 2008, 64:239-246.
160. Williams A.J., Paulson H.L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci 2008, 31:521-528.
161. Williams A.J., Knutson T.M., Colomer Gould V.F., et al. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Neurobiol Dis 2009, 33:342-353.
162. Wullner U., Schmitt I., Kammal M., et al. Definite multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry 2009, 80:449-450.
163. Wu Y.R., Lin H.Y., Chen C.M., et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 2004, 65:209-214.
164. Wyttenbach A. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis. J Mol Neurosci 2004, 23:69-96.
165. Xia H., Mao Q., Eliason S.L., et al. Rnai suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004, 10:816-820.
166. Yabe I., Sasaki H., Chen D.H., et al. Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. Arch Neurol 2003, 60:1749-1751.
167. Yamashita I., Sasaki H., Yabe I., et al. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cm interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann Neurol 2000, 48:156-163.
168. Yokoyama T., Mohri S. Prion diseases and emerging prion diseases. Curr Med Chem 2008, 15:912-916.
169. Yoshida H., Yoshizawa T., Shibasaki F., et al. Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch. Neurobiol Dis 2002, 10:88-99.
170. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997, 15:62-69.
171. Zhu D., Burke C., Leslie A., et al. Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion. Mov Disord 2002, 17:585-589.
172. Zuhlke C., Hellenbroich Y., Dalski A., et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 2001, 9:160-164.
173. Zu T., Duvick L.A., Kaytor M.D., et al. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci 2004, 24:8853-8861.